171 related articles for article (PubMed ID: 38233507)
21. Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling.
Almeida SFF; Santos L; Sampaio-Ribeiro G; Ferreira HRS; Lima N; Caetano R; Abreu M; Zuzarte M; Ribeiro AS; Paiva A; Martins-Marques T; Teixeira P; Almeida R; Casanova JM; Girão H; Abrunhosa AJ; Gomes CM
J Exp Clin Cancer Res; 2023 Nov; 42(1):328. PubMed ID: 38031171
[TBL] [Abstract][Full Text] [Related]
22. A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis.
Takemoto A; Okitaka M; Takagi S; Takami M; Sato S; Nishio M; Okumura S; Fujita N
Sci Rep; 2017 Feb; 7():42186. PubMed ID: 28176852
[TBL] [Abstract][Full Text] [Related]
23. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.
Xie G; Ji A; Yuan Q; Jin Z; Yuan Y; Ren C; Guo Z; Yao Q; Yang K; Lin X; Chen L
Br J Cancer; 2014 May; 110(10):2514-23. PubMed ID: 24755887
[TBL] [Abstract][Full Text] [Related]
24. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
[TBL] [Abstract][Full Text] [Related]
25. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM
Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model.
Christowitz C; Davis T; Isaacs A; van Niekerk G; Hattingh S; Engelbrecht AM
BMC Cancer; 2019 Aug; 19(1):757. PubMed ID: 31370818
[TBL] [Abstract][Full Text] [Related]
27. Tumour cell-activated platelets modulate the immunological activity of CD4
Gockel LM; Nekipelov K; Ferro V; Bendas G; Schlesinger M
Cancer Immunol Immunother; 2022 Oct; 71(10):2523-2533. PubMed ID: 35285006
[TBL] [Abstract][Full Text] [Related]
28. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments.
Taubenberger AV; Bray LJ; Haller B; Shaposhnykov A; Binner M; Freudenberg U; Guck J; Werner C
Acta Biomater; 2016 May; 36():73-85. PubMed ID: 26971667
[TBL] [Abstract][Full Text] [Related]
29. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
Velloso FJ; Campos AR; Sogayar MC; Correa RG
BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
[TBL] [Abstract][Full Text] [Related]
30. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
Pang JH; Coupland LA; Freeman C; Chong BH; Parish CR
Clin Exp Metastasis; 2015 Jun; 32(5):495-505. PubMed ID: 25982688
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo.
Pather K; Augustine TN
Sci Rep; 2020 Nov; 10(1):19256. PubMed ID: 33159119
[TBL] [Abstract][Full Text] [Related]
32. ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion.
Steinhaeuser SS; Morera E; Budkova Z; Schepsky A; Wang Q; Rolfsson O; Riedel A; Krueger A; Hilmarsdottir B; Maelandsmo GM; Valdimarsdottir B; Sigurdardottir AK; Agnarsson BA; Jonasson JG; Ingthorsson S; Traustadottir GA; Oskarsson T; Gudjonsson T
Lab Invest; 2020 Jul; 100(7):928-944. PubMed ID: 32203150
[TBL] [Abstract][Full Text] [Related]
33. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
[TBL] [Abstract][Full Text] [Related]
34. The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon.
Spillane CD; Cooke NM; Ward MP; Kenny D; Blackshields G; Kelly T; Bates M; Huang Y; Martin C; Skehan S; Canney A; Gallagher M; Smyth P; Brady N; Clarke A; Mohamed B; Norris L; Brooks DA; Brooks RD; Heatlie JK; Selemidis S; Hanniffy S; Dixon E; Sheils O; O'Toole SA; O'Leary JJ
Transl Oncol; 2021 Dec; 14(12):101229. PubMed ID: 34592589
[TBL] [Abstract][Full Text] [Related]
35. Impact of breast cancer cells´ secretome on the brain metastatic niche remodeling.
Carvalho R; Paredes J; Ribeiro AS
Semin Cancer Biol; 2020 Feb; 60():294-301. PubMed ID: 31711993
[TBL] [Abstract][Full Text] [Related]
36. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
37. Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions.
Holen I; Nutter F; Wilkinson JM; Evans CA; Avgoustou P; Ottewell PD
Clin Exp Metastasis; 2015 Oct; 32(7):689-702. PubMed ID: 26231669
[TBL] [Abstract][Full Text] [Related]
38. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.
Mohammed ZM; Going JJ; Edwards J; Elsberger B; Doughty JC; McMillan DC
Br J Cancer; 2012 Aug; 107(5):864-73. PubMed ID: 22878371
[TBL] [Abstract][Full Text] [Related]
39. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
40. Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer.
Ross JB; Huh D; Noble LB; Tavazoie SF
Nat Cell Biol; 2015 May; 17(5):651-64. PubMed ID: 25866923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
